Economic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications.
Huskamp
Haiden A
HA
Harvard Medical School, 180 Longwood Ave, Boston, Massachusetts 02115, USA. huskamp@hcp.med.harvard.edu
Shinogle
Judith A
JA
D003363:Cost Control; D003365:Costs and Cost Analysis / Q000191:economics; D016527:Drug Costs / Q000706:statistics & numerical data*; D004345:Drug Industry / Q000191:economics; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D006278:Medicare / Q000191:economics*; D017008:Negotiating; D011619:Psychotropic Drugs / Q000191:economics*; D014481:United States
D011619:Psychotropic Drugs